At Pangaea Ventures, we invest in bold hard tech innovations reshaping the future of industry and solving our planet’s (and its people’s) most pressing challenges. Kanvas Biosciences is a quintessential example leveraging groundbreaking spatial biology technology and precision microbiome therapeutics to address untapped opportunities in medicine and beyond. Here’s why we’ve invested again.

Co-led by DCVC and Lions Capital with participation from the Gates Foundation, ATHOS, Germin8, Ki Tua Fund, Pangaea Ventures and others, the round will fund clinical trials for Kanvas’ lead drug candidates and more.

In Part 1 of the Agtech Reset series, we explored how a decade of misaligned capital and expectations left many ag and foodtech innovations stranded, even as fundamentals strengthened. In Part 2, we turn to the practical question: where, exactly, are the opportunities, and what does it mean to both fund and fix them.

The Agtech Reset Part 1 examines how agtech and foodtech went from hyper-growth to capital drought, why strong technologies were left stranded, and how compressing valuations plus persistent food-system pressures are creating a specialist investor opportunity.

With decades of experience scaling industrial businesses, Kravtsov will focus on expanding CarbonCure’s CO₂ utilization technology across more producers and regions.

The funding will accelerate commercialization and global deployment of pH7’s closed-loop platform, enabling economic recovery of critical minerals from low-grade ores, tailings, and complex feedstocks that were previously uneconomic to process.

Pangaea Ventures is excited to welcome Kandai Yamashita as our new investment lead in Tokyo, further strengthening Pangaea’s long-standing partnership model with corporate limited partners and Japan’s hard tech ecosystem.

Pangaea Venturesは、東京に於ける新たな投資担当として山下 寛大（Kandai Yamashita）を迎えることになりました。これにより、当社が長年培ってきたコーポレートLPとのパートナーシップモデルと日本のHard Tech Ecosystemとの繋がりをより一層強化していきます。

Aspect Biosystems has announced a $280M partnership with Government of Canada to accelerate development of its bioengineered cellular medicines for serious metabolic and endocrine diseases.

We’re often asked why our US office is in Phoenix. To us, the answer is clear. Arizona offers an unusually strong fit for hard tech: a rising startup hub, a deep pipeline of engineering and scientific talent, concentration in advanced manufacturing and semiconductors, and a supportive policy and business environment.

pH7 Technologies is expanding its Vancouver facility to boost North American recovery of critical platinum group metals from recycled materials, while cutting wastewater, energy use, and carbon footprint relative to conventional refining.

Kanvas Biosciences has received the green light to begin enrolling and treating patients in a Phase 1 clinical trial of KAN-004, a live biotherapeutic designed to treat immune checkpoint inhibitor–induced colitis

Photonic networking offers a way around today’s bottlenecks by moving more of the data path into the optical domain, where light can carry far more information with lower loss than copper. This shift is not just another speed bump on a roadmap, it is part of a broader hard tech revolution in compute and networking infrastructure, where materials innovation and systems-level design are reshaping what is possible in AI-era data centers.

If you search for a definition of hard tech, you’ll find it can be fluid. As a pioneer in hard tech investing we've been researching and investing in this sector for many years and have formed our own thesis on what is hard tech and why hard tech innovation matters.

InSolare Energy and Versogen have entered a technology transfer and strategic collaboration to jointly develop and commercialize advanced AEM electrolyzer stacks for India’s green hydrogen market.

Kanvas Biosciences has welcomed Dr. Stephen Quake to its Board of Directors, adding one of the world’s leading bioengineers to an already strong team.

The honor validates Tidal Vision’s thesis that biosolutions win at scale only when they outcompete on performance, economics, and ease of use, and highlights the team’s progress bringing chitosan‑based chemistry into water treatment, agriculture, and materials applications.

TS601 builds on NewLeaf’s PPFM platform and induced systemic resistance mode of action, giving growers a new biological tool to protect yield while supporting more sustainable production.

We’re proud to see pH7 Technologies named a finalist in Wheaton Precious Metals’ 2025/2026 Future of Mining Challenge, recognizing solutions that can reshape how the industry sources critical metals.

By replacing abrasive slurries with a chemically reactive pad and polishing fluid, Chakra is designed to improve yield, reduce water and waste, and help enable advanced AI chips, HBM, and cutting‑edge packaging flows.

Robotics is entering a phase where simply “seeing” the world is not enough. Tactile robotics adds the sense of touch, allowing robots to understand force, texture, slip, temperature, and deformation so they can handle fragile objects, work safely alongside people, and operate reliably in unstructured environments. For corporate investors, this is a critical enabling layer of the ongoing hard tech revolution.